If you have axial psoriatic arthritis that’s moderate to severe and NSAIDs are not helping, doctors often prescribe meds called DMARDs (disease-modifying antirheumatic drugs).

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

Psoriatic arthritis represents one of the more challenging inflammatory conditions in rheumatology, ... Others develop axial involvement targeting the spine and sacroiliac joints.

UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) ...

"Psoriatic arthritis and axial spondyloarthritis are serious, chronic inflammatory diseases that can have a great impact in the daily lives of patients and their families. The data presented at ...

A large PsA cohort study found metabolic syndrome linked to spine and enthesis degeneration, but not to radiographic joint ...

"Psoriatic arthritis and axial spondyloarthritis are serious, chronic inflammatory diseases that can have a great impact in the daily lives of patients and their families. The data presented at ...

UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...

"Psoriatic arthritis and axial spondyloarthritis are serious, chronic inflammatory diseases that can have a great impact in the daily lives of patients and their families. The data presented at ...

"Psoriatic arthritis and axial spondyloarthritis are serious, chronic inflammatory diseases that can have a great impact in the daily lives of patients and their families. The data presented at ...